对ABI3 p.Ser209Phe变体的遗传验证及其对无症状老年人早期脑病理的影响
Mikko Koivumäki1,2, Henna Martiskainen3, Mari Takalo3
1Turku PET Centre, University of Turku, Turku, Finland. mikkkoi@utu.fi.
Alzheimer's research & therapy
|February 19, 2026
概括
ABI3S209F基因变异增加了阿尔茨海默病的风险,并导致早期发病. 它的效果在与APOE ε4变体结合时显得更加明显,影响粉样蛋白β沉积.
科学领域:
- 遗传学 是一个遗传学.
- 神经科学是一个神经科学.
- 免疫学 免疫学 免疫学
背景情况:
- 阿尔茨海默病 (AD) 具有显著的遗传基础,APOE ε4 是影响β-粉样蛋白 (Aβ) 代谢和微质功能的主要危险因素.
- 最近的研究强调了微质基因,如ABI3S209F变体,作为AD风险的潜在贡献者.
- 调查APOE ε4和ABI3S209F的联合作用可能为AD病理生理学提供新的见解,因为它们的机制不同.
研究的目的:
- 调查ABI3S209F变种与阿尔茨海默病风险和发病的关联.
- 检查ABI3S209F和APOE ε4对AD相关生物标志物和神经成像发现的综合影响.
- 在一个大型芬兰队列 (FinnGen) 和一个独立的成像研究中分析ABI3S209F.
主要方法:
- 利用FinnGen R12数据 (>500,000个体) 进行生存分析,比较8,490个ABI3S209F载体与非载体.
- 定义疾病终点 (AD,痴呆症,神经退行性疾病) 使用国家卫生登记处数据.
- 在三个基因型组 (ABI3S209F/APOE ε4,ABI3S209F/APOE ε3,对照组) 进行了58名参与者 (≥50岁) 的成像研究,采用结构性MRI,粉样PET ([11C]PiB),微质PET ([11C]PK11195),以及神经心理测试.
主要成果:
- ABI3S209F与AD (OR=1.22) 和神经退行性疾病 (OR=1.21) 的风险增加有显著联系.
- 与具有相同APOE基因型的非载体相比,ABI3S209F载体经历了较早的AD发病.
- 结合ABI3S209F和APOE ε4载体显示出比ABI3S209F载体没有APOE ε4更高的大脑Aβ负担;单独ABI3S209F没有显著影响Aβ,神经炎症或大脑结构.
结论:
- ABI3S209F变种增加了阿尔茨海默病的风险,并且与早期发病年龄有关.
- 在认知健康的个体中,ABI3S209F不会独立影响皮质Aβ沉积,神经炎症或大脑结构.
- 与ABI3S209F相关的风险可能会在存在APOE ε4变种时被放大.
相关概念视频
Single Nucleotide Polymorphisms-SNPs
A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
Principles of Pharmacogenetics: Types of Genetic Variants
The human genome is over 99.9% identical between individuals, yet genetic differences exist at millions of bases. The human genome contains approximately 3 million variant positions per individual, many of which are heterozygous, contributing to genetic diversity and individual traits. Genetic variations include single-nucleotide polymorphisms (SNPs), insertions, deletions, and copy number variations (CNVs).SNPs, the most common variation, involve single-base changes in DNA. These can be...
Human Genetics
Human genetics provides a profound framework for understanding the interplay between genetic predispositions and human psychology. At the heart of this discipline lies the study of how genes influence physical traits, behaviors, and susceptibility to diseases. Each person carries a unique genetic code that subtly or significantly shapes their psychological and behavioral landscape.
The complex relationship between genetics and psychology is observable through common biological components such...
The complex relationship between genetics and psychology is observable through common biological components such...
Alzheimer Disease l: Introduction
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
Alzheimer Disease ll: Pathophysiology
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
Huntington Disease l: Introduction
Huntington disease or HD is a progressive, fatal neurodegenerative disorder inherited in an autosomal dominant pattern.PathophysiologyIt is caused by expansion of the CAG trinucleotide repeat in the HTT gene on chromosome 4 (4p16.3), producing an abnormal huntingtin protein with an expanded polyglutamine tract. This misfolded protein disrupts cellular function, leading to neuronal death. Normal alleles have ≤26 repeats, 27–35 are intermediate (risk of expansion), 36–39 show reduced penetrance,...


